DK3639829T3 - Anvendelse af isovalerylspiramycin i eller iii ved fremstilling af lægemiddel til behandling og/eller forebyggelse af tumor samt lægemiddel - Google Patents
Anvendelse af isovalerylspiramycin i eller iii ved fremstilling af lægemiddel til behandling og/eller forebyggelse af tumor samt lægemiddel Download PDFInfo
- Publication number
- DK3639829T3 DK3639829T3 DK18827765.1T DK18827765T DK3639829T3 DK 3639829 T3 DK3639829 T3 DK 3639829T3 DK 18827765 T DK18827765 T DK 18827765T DK 3639829 T3 DK3639829 T3 DK 3639829T3
- Authority
- DK
- Denmark
- Prior art keywords
- medicines
- tumors
- prevention
- iii
- manufacture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710537958 | 2017-07-04 | ||
| CN201711450396 | 2017-12-27 | ||
| CN201711497546 | 2017-12-27 | ||
| CN201711450300 | 2017-12-27 | ||
| PCT/CN2018/094504 WO2019007368A1 (zh) | 2017-07-04 | 2018-07-04 | 异戊酰螺旋霉素i、ii和/或iii在制备治疗和/或预防肿瘤药物方面的应用和药物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3639829T3 true DK3639829T3 (da) | 2022-05-16 |
Family
ID=64950608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18827765.1T DK3639829T3 (da) | 2017-07-04 | 2018-07-04 | Anvendelse af isovalerylspiramycin i eller iii ved fremstilling af lægemiddel til behandling og/eller forebyggelse af tumor samt lægemiddel |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20200163984A1 (da) |
| EP (1) | EP3639829B1 (da) |
| JP (1) | JP7060631B2 (da) |
| KR (1) | KR102375444B1 (da) |
| CN (1) | CN110869027B (da) |
| AU (1) | AU2018298187A1 (da) |
| CA (1) | CA3068921A1 (da) |
| DK (1) | DK3639829T3 (da) |
| ES (1) | ES2912734T3 (da) |
| MX (1) | MX2019015676A (da) |
| RU (1) | RU2766176C2 (da) |
| WO (1) | WO2019007368A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2771046C2 (ru) | 2018-01-19 | 2022-04-25 | Шенянг Фуянг Фармасьютекал Технолоджи Ко., Лтд. | Применение карримицина или его активных ингредиентов |
| US20200405739A1 (en) * | 2018-01-19 | 2020-12-31 | Shenyang Fuyang Pharmaceutical Technology Co., Ltd. | Mtor inhibitor, pharmaceutical composition and use thereof |
| CA3142427A1 (en) * | 2019-05-16 | 2020-11-19 | Shenyang Fuyang Pharmaceutical Technology Co., Ltd. | Medicament and combination product used for preventing, alleviating and/or treating fibrosis, and use thereof |
| US11351185B2 (en) | 2020-03-11 | 2022-06-07 | Asclea Corporation | Use of isovalerylspiramycins as anti-cancer agents to inhibit metastasis |
| CN113577086B (zh) * | 2020-04-30 | 2023-05-02 | 沈阳福洋医药科技有限公司 | 异戊酰螺旋霉素类化合物或其组合物在制备治疗免疫失调的药物中的应用 |
| CN113372397A (zh) * | 2021-06-22 | 2021-09-10 | 天方药业有限公司 | 一种己二酸螺旋霉素的制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1540397A (en) * | 1976-12-08 | 1979-02-14 | May & Baker Ltd | Spiramycin esters |
| CA2127578A1 (en) * | 1993-07-08 | 1995-01-09 | Keiichi Ajito | 16-membered macrolide derivatives and process for producing the same |
| US7087237B2 (en) | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
| JP2009539970A (ja) | 2006-06-12 | 2009-11-19 | ラモット アット テル−アビブ ユニバーシティー リミテッド | 癌の治療方法 |
| CN101362784A (zh) | 2008-10-06 | 2009-02-11 | 山东大学 | 埃博霉素苷类化合物和以其为活性成分的组合物及其应用 |
| CN101773510B (zh) | 2010-03-09 | 2013-06-05 | 沈阳同联集团有限公司 | 异戊酰螺旋霉素iii的分离制备 |
| CN101785779B (zh) | 2010-03-09 | 2014-03-05 | 沈阳同联集团有限公司 | 异戊酰螺旋霉素ii的分离制备 |
| CN101785778A (zh) | 2010-03-09 | 2010-07-28 | 沈阳同联集团有限公司 | 异戊酰螺旋霉素i的分离制备及其应用 |
| CN102229634B (zh) * | 2010-05-25 | 2014-05-28 | 沈阳同联集团有限公司 | 左旋异戊酰螺旋霉素i、其制剂、制备方法及应用 |
| DK2578595T3 (da) * | 2010-05-25 | 2017-07-10 | Shenyang Fuyang Pharmaceutical Tech Co Ltd | Krystallinsk levoisovalerylspiramycin i |
| IN2012MN02623A (da) * | 2010-05-25 | 2015-06-12 | Shenyang tonglian group co ltd | |
| AU2018247555B2 (en) * | 2017-04-06 | 2024-04-18 | Shenyang Fuyang Pharmaceutical Technology Co., Ltd. | Use of carrimycin and pharmaceutically acceptable salt thereof for manufacture of medicament for treatment and/or prevention of tumors |
-
2018
- 2018-07-04 ES ES18827765T patent/ES2912734T3/es active Active
- 2018-07-04 RU RU2020102713A patent/RU2766176C2/ru active
- 2018-07-04 WO PCT/CN2018/094504 patent/WO2019007368A1/zh unknown
- 2018-07-04 MX MX2019015676A patent/MX2019015676A/es unknown
- 2018-07-04 US US16/627,102 patent/US20200163984A1/en not_active Abandoned
- 2018-07-04 CA CA3068921A patent/CA3068921A1/en active Pending
- 2018-07-04 AU AU2018298187A patent/AU2018298187A1/en not_active Abandoned
- 2018-07-04 CN CN201880019070.8A patent/CN110869027B/zh active Active
- 2018-07-04 JP JP2019571958A patent/JP7060631B2/ja active Active
- 2018-07-04 KR KR1020207002990A patent/KR102375444B1/ko active IP Right Grant
- 2018-07-04 EP EP18827765.1A patent/EP3639829B1/en active Active
- 2018-07-04 DK DK18827765.1T patent/DK3639829T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3639829A1 (en) | 2020-04-22 |
| WO2019007368A1 (zh) | 2019-01-10 |
| CA3068921A1 (en) | 2019-01-10 |
| RU2766176C2 (ru) | 2022-02-08 |
| EP3639829A4 (en) | 2020-06-24 |
| RU2020102713A (ru) | 2021-08-04 |
| EP3639829B1 (en) | 2022-02-09 |
| ES2912734T3 (es) | 2022-05-27 |
| JP7060631B2 (ja) | 2022-04-26 |
| CN110869027A (zh) | 2020-03-06 |
| US20200163984A1 (en) | 2020-05-28 |
| CN110869027B (zh) | 2023-09-08 |
| KR102375444B1 (ko) | 2022-03-17 |
| AU2018298187A1 (en) | 2020-02-06 |
| MX2019015676A (es) | 2022-03-17 |
| JP2020528047A (ja) | 2020-09-17 |
| KR20200024280A (ko) | 2020-03-06 |
| RU2020102713A3 (da) | 2021-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3639829T3 (da) | Anvendelse af isovalerylspiramycin i eller iii ved fremstilling af lægemiddel til behandling og/eller forebyggelse af tumor samt lægemiddel | |
| DK3153169T3 (da) | Fremgangsmåde til behandling af tumor, farmaceutisk sammensætning og medicinæskesæt | |
| ZA201806819B (en) | Pharmaceutical combinations for the treatment of cancer | |
| EP3533466A4 (en) | PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND / OR PREVENTION | |
| IL266623A (en) | A pharmaceutical preparation for use in the therapeutic treatment of cancer and complications of cancer | |
| HK1250950A1 (zh) | 曲美他嗪在製備防治肝病的藥物中的用途 | |
| BR112017025255A2 (pt) | métodos, produto, produto de programa de computador, sistema, e composições farmacêuticas estimulante e inibidora para uso no tratamento ou prevenção do câncer de próstata | |
| IL266486A (en) | Pharmaceutical preparations and methods for cancer treatment | |
| HK1257239A1 (zh) | 預防和治療肥胖症的藥物及其用途 | |
| EP3411122A4 (en) | CANCER VACCINES AND TREATMENT METHODS THEREWITH | |
| IL280587B (en) | Fluorocitidine derivatives and their preparations for use in cancer treatment | |
| HK1257587A1 (zh) | 預防和治療肝纖維化的藥物及其用途 | |
| HK1255689A1 (zh) | 三乙酰基-3-羥基苯基腺苷在製備預防或者治療非酒精性脂肪肝藥物中的應用 | |
| DK3454879T3 (da) | Hidtil ukendte forbindelser og farmaceutisk anvendelse deraf i behandlingen af kræft | |
| DK3290051T3 (da) | Farmaceutisk sammensætning til behandling og/eller forebyggelse af cancer | |
| HK1257238A1 (zh) | 預防和治療脂質腎損傷的藥物及其用途 | |
| HK1257590A1 (zh) | 預防和治療藥物性腎損傷的藥物及其用途 | |
| HK1246639A1 (zh) | 口服藥物組合物和其用於製備治療或預防疾病的藥物的用途 | |
| EP3563856A4 (en) | PHARMACEUTICAL COMPOSITION FOR TREATING CANCER AND USE THEREOF | |
| KR101913693B9 (ko) | SS18-SSX 융합 유전자 특이적 siRNA 및 이를 포함하는 암 예방 또는 치료용 약학적 조성물 | |
| IL249860A0 (en) | Pharmaceutical preparations, methods for their preparation and their use for the treatment of cancer | |
| EP3372233A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER | |
| PT3236961T (pt) | Composição farmacêutica para prevenir ou tratar cancro | |
| PL3458019T3 (pl) | Preparat do terapii i profilaktyki w zakresie syndromu wypalenia dotykającego skórę głowy i skórę | |
| IL281782A (en) | Drug combination for cancer treatment |